Prepatellar bursitis

1. High-Yield Summary

Prepatellar bursitis is an inflammatory condition characterized by fluid distension and synovial hypertrophy of the prepatellar bursal complex, an anatomical structure positioned between the anterior surface of the patella and the overlying subcutaneous tissue. Colloquially designated “housemaid’s knee” or “carpenter’s knee,” it represents one of the most frequent extra-articular disorders of the anterior knee encountered in occupational and sports medicine:

• Etiological Spectrum (Septic vs. Aseptic): The primary diagnostic imperative is distinguishing acute or chronic aseptic bursitis (secondary to repetitive mechanical shear, direct blunt trauma, or crystalline deposition such as gout or pseudogout) from acute septic bursitis resulting from transcutaneous bacterial inoculation, in which Staphylococcus aureus accounts for 80% to 90% of confirmed infectious cases.
• Cardinal Physical Examination Benchmark: A well-demarcated, fluctuant, dome-shaped swelling strictly localized anterior to the patellar bone. Passive range of motion demonstrates preserved, painless knee flexion beyond 90 degrees with active discomfort occurring only at terminal flexion due to cutaneous tension; this contrasts sharply with the global, agonizing restriction of motion and involuntary capsular guarding characteristic of intra-articular septic arthritis.
• Mandatory Diagnostic Aspiration: Immediate percutaneous needle aspiration under strict aseptic conditions via a lateral or anterolateral extra-articular trajectory is the definitive diagnostic maneuver for any erythematous, warm, or tense bursal collection. Synovial fluid leukocyte count (>10,000 to >50,000/μL with >50% to 80% polymorphonuclear cells), Gram stain, aerobic and anaerobic cultures, and polarized light microscopy establish or exclude infection and crystalline disease.
• Nonoperative Management Framework: Conservative treatment resolves over 85% to 90% of acute aseptic cases through cryotherapy, NSAIDs, compressive bandaging, and strict avoidance of unpadded kneeling. Intrabursal corticosteroid injections are cautioned against due to a 5% to 15% risk of skin atrophy, chronic fistulization, and secondary iatrogenic infection. Uncomplicated septic bursitis responds to targeted oral or intravenous antimicrobials (e.g., cephalexin, cefazolin, or vancomycin/trimethoprim-sulfamethoxazole for MRSA) coupled with serial needle aspirations or closed catheter drainage.
• Surgical Bursectomy Triggers: Operative intervention (open or endoscopic bursectomy) is reserved for chronic, refractory, disabling aseptic bursitis persisting after 3 to 6 months of comprehensive nonoperative care, or acute septic bursitis complicated by peribursal necrosis, purulent phlegmon, systemic toxicity, or failure of clinical regression after 48 to 72 hours of targeted antibiotic therapy and closed drainage.

2. Anatomy

Prepatellar Bursal Complex & Trilaminar Architecture

The prepatellar bursa is not a solitary monocameral sac, but rather an intricate trilaminar bursal complex functioning as a specialized low-friction gliding interface that dissipates compressive and shear loads between the anterior integument and the rigid osseous surface of the patella. Anatomical and histological dissections demonstrate three distinct, anatomically stratified components:

• Subcutaneous Prepatellar Bursa (Bursa praepatellaris subcutanea): Situated between the deep layer of the superficial subcutaneous fascia and the superficial investing prepatellar aponeurosis. This is the largest, most superficial, and most clinically vulnerable component of the complex, accounting for the vast majority of acute traumatic, occupational, and infectious bursitis presentations.
• Subfascial (Subaponeurotic) Prepatellar Bursa: Positioned between the intermediate fibrous expansions of the fascia lata and the rectus femoris/quadriceps aponeurosis and the deep investing fascia. It provides intermediate shear dissipation during dynamic quadriceps contraction.
• Subtendinous Prepatellar Bursa: Located between the deep intermediate tendinous fibers of the quadriceps expansion and the anterior periosteum covering the cortical bone of the patella.

Anatomically, the prepatellar bursal complex is entirely extra-articular and separated from the true knee joint cavity by the dense anterior patellar cortex, the robust fibers of the patellar tendon, and the anterior fibrous capsule. It is geographically distinct from the adjacent infrapatellar bursae (the superficial infrapatellar bursa anterior to the tibial tubercle and the deep infrapatellar bursa between the distal patellar tendon and proximal tibia) and the suprapatellar bursa (which represents a direct superior extension of the intra-articular synovial cavity). Under normal anatomical conditions, no communication exists between the prepatellar bursa and the knee joint space.

Microanatomy & Synovial Fluid Dynamics

The internal lining of the prepatellar bursa is composed of a discontinuous layer of specialized synoviocytes measuring one to three cells in thickness, devoid of a true epithelial basement membrane, resting upon a vascularized bed of loose fibroadipose connective tissue. The synoviocyte population comprises two functional cell types:

• Type A Synoviocytes (Macrophage-Like): Bone marrow-derived phagocytic cells possessing prominent cell-surface invaginations, lysosomes, and pinocytotic vesicles responsible for clearing cellular debris, metabolic breakdown products, and invading micro-organisms from the bursal lumen.
• Type B Synoviocytes (Fibroblast-Like): Mesenchymally derived secretory cells featuring extensive rough endoplasmic reticulum and Golgi complexes. These cells actively synthesize and secrete hyaluronic acid, lubricin (proteoglycan 4), and surface-active phospholipids into the bursal fluid.

Under non-pathological physiological conditions, the bursa contains only a scant capillary film (less than 0.5 mL) of clear, highly viscous lubricating fluid derived as an ultrafiltrate of blood plasma combined with synoviocyte-produced hyaluronic acid. Because the synoviocyte layer lacks an impermeable basement membrane, any mechanical or biochemical insult triggers rapid vascular permeability, leading to massive transudative or exudative fluid extravasation, inflammatory cell infiltration, and rapid macroscopic distension of the bursal sac.

Neurovascular Danger Zones & Adjacent Soft Tissue

Surgical intervention and percutaneous procedures within the prepatellar region involve several critical neurovascular structures and tissue envelopes that must be protected:

3. Pathogenesis

Biomechanical Shear & Repetitive Microtrauma

The primary mechanical driver of aseptic prepatellar bursitis is repetitive mechanical shear combined with unpadded direct compression. In the kneeling posture, contact pressures across the anterior knee can exceed 200 to 300 kPa, concentrated across a narrow bony contact area over the patella and proximal tibial tubercle. Body weight transfers directly onto the rigid anterior patellar cortical bone. Shifting, crawling, or pivoting while kneeling induces substantial tangential shear stress between the mobile anterior cutaneous envelope and the unyielding underlying osseous patella.

These repetitive shear stresses cause micro-traction injury to the capillary beds supplying the bursal synovial lining, producing focal capillary rupture, localized micro-hemorrhages, and cellular hypoxia. Injured synoviocytes and endothelial cells release damage-associated molecular patterns (DAMPs), inciting an acute local inflammatory cascade. Cytokines including interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and matrix metalloproteinases (MMPs) stimulate synoviocyte proliferation, intense synovial hypervascularity, and excessive fluid production. With ongoing unmitigated microtrauma, the bursal wall undergoes chronic fibrotic remodeling, marked by collagenous mural thickening, internal pseudoloculations, and the shedding of avascular fibrinous conglomerates known as “rice bodies” (corpuscula oryzoidea).

Aseptic Crystalline Arthropathy & Gouty Deposition

The prepatellar bursa represents the second most prevalent extra-articular site of crystalline deposition in the human body, following the olecranon bursa. In patients with chronic hyperuricemia, monosodium urate (MSU) crystals preferentially nucleate and precipitate within the prepatellar bursa due to lower local tissue temperatures over the subcutaneous anterior knee and repeated micro-vessel injury from mechanical pressure.

Phagocytosis of needle-shaped MSU crystals by Type A synoviocytes and resident tissue macrophages triggers assembly and activation of the intracellular NLRP3 inflammasome complex. This activates caspase-1, inducing rapid enzymatic cleavage of pro-IL-1β into mature, bioactive IL-1β. The resulting explosive cytokine release elicits profound vasodilation, intense erythema, severe local hyperthermia, and rapid neutrophil recruitment—a presentation termed “pseudoseptic bursitis” that closely mimics acute bacterial infection. Over time, recurring crystalline deposition promotes chalky tophaceous aggregates within the bursal walls, predisposing to chronic fibrotic bursal enlargement, calcification, and secondary cutaneous ulceration. Calcium pyrophosphate dihydrate (CPPD) crystal deposition can similarly induce an acute pseudogout bursitis.

Septic Bursitis Pathogenesis & Microbiological Inoculation

Septic prepatellar bursitis develops predominantly through direct transcutaneous bacterial inoculation rather than hematogenous dissemination. The anterior patellar skin is exposed to mechanical friction, abrasion, and puncture during manual labor or contact sports. Micro-fissures, excoriations, folliculitis, or minor penetrating trauma allow surface bacteria to penetrate directly into the subcutaneous bursal space. Once inside, the warm, protein-rich, relatively low-flow bursal fluid provides an ideal culture medium for bacterial proliferation.

• Staphylococcus aureus: The causative organism in 80% to 90% of culture-confirmed septic prepatellar bursitis cases. Methicillin-resistant S. aureus (MRSA) accounts for 25% to 40% of cases in contemporary clinical series, exhibiting elevated prevalence among contact athletes (wrestlers, football players) and individuals with prior healthcare exposures. Virulence factors such as fibronectin-binding proteins (FnBPA, FnBPB) allow S. aureus to adhere avidly to bursal synoviocytes and matrix proteins, while alpha-hemolysin and Panton-Valentine leukocidin (PVL) cause rapid tissue necrosis and extensive purulent exudation.
• Streptococcal Species: Streptococcus pyogenes (Group A Streptococcus) and other beta-hemolytic streptococci (Groups B, C, and G) constitute the second most common etiologic group (~10% to 15% of cases), typically presenting with rapid cellulitic spread, extensive peribursal lymphangitis, and systemic toxicity.
• Gram-Negative & Atypical Pathogens: Gram-negative bacilli (Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens) account for 2% to 5% of cases, occurring predominantly in immunocompromised hosts, intravenous drug users, or following aquatic injuries. Coagulase-negative staphylococci, fungi (Candida spp.), and atypical mycobacteria (Mycobacterium marinum, Mycobacterium chelonae) are rare, indolent culprits typically encountered following prior invasive needle aspirations or corticosteroid injections.
• Rarity of Hematogenous Seeding: Under normal baseline physiological conditions, the resting prepatellar bursa possesses minimal microvascular perfusion. True hematogenous bacterial seeding of a non-traumatized bursa is distinctly uncommon, occurring almost exclusively in patients with profound bacteremia, infective endocarditis, or severe immunosuppression.

4. Natural History

Epidemiology & Occupational Predilection

Prepatellar bursitis exhibits a striking demographic predilection for working-age males, with men accounting for 80% to 90% of documented clinical cases. The peak incidence spans individuals aged 20 to 55 years, reflecting active engagement in occupational trades requiring prolonged kneeling and high-impact contact athletics.

Occupational groups with the highest documented risk include carpet and linoleum layers, tile setters, floor installers, roofers, coal miners (“beat knee”), plumbers, masonry workers, concrete finishers, and domestic cleaners. Epidemiological surveys demonstrate that occupational floor layers have an odds ratio exceeding 3.0 for developing prepatellar bursitis compared to non-kneeling workers. In the athletic population, sports involving intense mat friction, abrasive surfaces, and direct blunt falls—most notably wrestling, Brazilian jiu-jitsu, judo, mixed martial arts, rugby, and basketball—carry high rates of both traumatic acute aseptic and secondary septic bursitis.

Clinical Progression & Prognostic Trajectory

The clinical trajectory of prepatellar bursitis is dictated by etiology, host immune competence, and the timeliness of therapeutic intervention:

• Acute Aseptic Bursitis: Follows a benign, self-limiting course when mechanical kneeling is halted immediately. Inflammatory fluid typically undergoes spontaneous reabsorption over 2 to 3 weeks. However, if unpadded kneeling continues, the condition progresses to chronic proliferative bursitis. The bursal membrane thickens into a dense fibrotic wall measuring up to 5 to 10 mm, resulting in a persistent, palpable anterior mass that causes mechanical restriction during full knee flexion.
• Acute Septic Bursitis: Follows a rapidly progressive, destructive trajectory over 24 to 72 hours. Uncontrolled bacterial replication and intense neutrophil infiltration lead to intrabursal suppuration, enzymatic tissue liquefaction, and marked elevation of bursal compartmental pressure.
• Peribursal Phlegmon & Cutaneous Necrosis: As high-pressure purulence breaches the thin subcutaneous bursal wall, infection infiltrates the surrounding subcutaneous adipose tissue, producing a florid peribursal phlegmon and spreading cellulitis. Cutaneous ischemia over the apex of the distended patella leads to full-thickness skin necrosis and spontaneous purulent rupture, establishing a chronic draining cutaneous sinus tract.
• Secondary Joint Sepsis & Patellar Osteomyelitis: If the deep prepatellar aponeurosis and patellar periosteum are eroded by severe necrotizing infection—or violated by inappropriate needle manipulation—purulence can track directly into the anterior cortex of the patella, causing patellar osteomyelitis. Furthermore, tracking into the adjacent capsular reflections of the suprapatellar recess can convert an isolated extra-articular bursitis into catastrophic intra-articular septic arthritis of the knee joint. Systemic bacteremic seeding, sepsis, and metastatic seeding of distant prostheses represent life-threatening endpoints in neglected cases.

5. Clinical Presentation

History

A structured clinical history is critical to ascertain the underlying etiology, duration of symptoms, and host risk profile:

• Occupational & Recreational Exposures: Quantify daily hours spent kneeling, contact surfaces (concrete, hardwood, carpet, wrestling mats), and whether protective knee padding was utilized.
• Onset & Tempo of Swelling: An acute, explosive onset of swelling over hours following direct blunt trauma suggests traumatic hemobursa. Rapid swelling developing over 24 to 48 hours accompanied by intense heat and erythema strongly points toward acute bacterial infection or crystalline disease. An insidious, painless swelling evolving over weeks or months indicates chronic mechanical bursitis.
• Integumentary Integrity: Specifically query preceding skin trauma, including minor scrapes, mat burns, puncture wounds, insect bites, or recent local folliculitis.
• Prior Interventions & Injections: Document prior needle aspirations, drainage procedures, or local corticosteroid injections, which significantly heighten the risk of refractory or atypical infections.
• Host Immune & Comorbidity Status: Screen for diabetes mellitus (associated with atypical pathogens and treatment failure), chronic kidney disease, systemic immunosuppression, active alcohol use disorder, rheumatoid arthritis, and a personal or family history of gout.
• Systemic Symptoms: Inquire about subjective fevers, rigors, night sweats, and generalized malaise. Notably, subjective fever is absent in up to 50% to 60% of patients with culture-proven septic bursitis; its absence must never be used to exclude infection.

Physical Examination & Provocative Maneuvers

Physical examination must systematically distinguish extra-articular prepatellar pathology from intra-articular knee joint pathology through disciplined inspection, palpation, and range of motion testing:

• Inspection: Classical prepatellar bursitis demonstrates a discrete, dome-shaped, well-circumscribed fluctuant mass centered directly over the anterior aspect of the patella and proximal patellar tendon. The normal parapatellar gutters and suprapatellar pouch remain concavely contoured and empty, demonstrating the absence of intra-articular effusion. Inspect the overlying skin for focal erythema, warmth, excoriations, pustules, puncture marks, or cutaneous necrosis.
• Palpation: Palpate for localized calor, focal tenderness maximal directly over the patella, and fluid ballottement. The fluid wave is strictly confined to the prepatellar sac and cannot be displaced into the medial or lateral joint gutters.
• The Crucial Differentiating Test (The 90-Degree Passive Flexion Benchmark): Active and passive range of motion must be meticulously evaluated. In prepatellar bursitis (both aseptic and septic), the intra-articular joint space is uninflamed. Consequently, passive knee flexion from 0 to 90 degrees is typically preserved and completely painless. Discomfort is elicited only near terminal passive flexion (>90 to 120 degrees) as the overlying cutaneous envelope stretches tightly over the distended bursa. Active extension against resistance is preserved without significant extensor lag. In sharp contrast, patients with true intra-articular septic arthritis exhibit agonizing pain throughout all planes of passive movement, hold the knee rigidly in 20 to 30 degrees of loose-pack flexion, and demonstrate profound involuntary muscular guarding even upon minor degrees of joint motion.

Differential Diagnosis

Differentiating prepatellar bursitis from other conditions causing anterior knee swelling is essential to avoid catastrophic diagnostic errors, such as performing an unnecessary emergency arthrotomy for extra-articular bursitis, or failing to decompress true joint sepsis:

6. Imaging and Diagnostic Studies

Plain Radiography

Standard radiographic evaluation of anterior knee swelling requires a minimum of three views: a standing weight-bearing anteroposterior (AP) view, a true lateral view at 30 degrees of knee flexion, and an axial patellofemoral view (Merchant or sunrise view). Key diagnostic observations include:

• Soft-Tissue Profile: Identifies prominent, localized soft-tissue swelling directly anterior to the patellar shadow. Critically, the lateral radiograph reveals clear, radiolucent quadriceps and prefemoral fat pads without distension of the suprapatellar pouch, confirming the absence of significant intra-articular knee effusion.
• Osseous Integrity: Excludes acute undisplaced, transverse, or vertical patellar fractures that can mimic acute post-traumatic bursitis. Also differentiates bipartite patella (typically superolateral with smooth, rounded sclerotic margins) from acute cortical fracture lines.
• Foreign Body Detection: Identifies radio-opaque penetrating foreign bodies such as gravel, glass fragments, metallic needles, or wire debris that may have seeded the subcutaneous tissues during occupational kneeling or trauma.
• Exclusion of Patellar Osteomyelitis: Evaluates for focal cortical destruction, anterior cortical permeative osteolysis, or periosteal reaction denoting secondary contiguous patellar osteomyelitis.
• Crystalline Calcification: Demonstrates amorphous soft-tissue calcification or dense tophaceous masses overlying the patella, accompanied by classic periarticular osseous erosions with sclerotic overhanging edges characteristic of chronic tophaceous gout, or linear chondrocalcinosis in CPPD.

Diagnostic Aspiration (Gold Standard)

Diagnostic needle aspiration is the indisputable gold standard investigation and must be performed promptly in any patient presenting with an acutely inflamed, erythematous, warm, or tense prepatellar collection prior to the administration of systemic antibiotics. The procedure serves both diagnostic and therapeutic decompression purposes:

• Aseptic Aspiration Technique: Prepare the skin meticulously with 2% chlorhexidine gluconate in 70% isopropyl alcohol. Infiltrate a small subcutaneous wheal of 1% plain lidocaine into intact skin lateral to the bursa, taking care not to inject anesthetic into the bursal fluid cavity itself. Introduce an 18-gauge to 20-gauge needle mounted on a 10 to 20 mL syringe through normal, non-erythematous skin via a strictly lateral or superolateral approach. Direct the needle tangentially across the anterior cortical surface of the patella into the center of the fluctuance.
• Absolute Procedural Precautions: Never introduce the needle through ulcerated, necrotic, or compromised skin. Never angle the needle posteriorly toward the patellofemoral joint space or through the patellar tendon, as accidental capsular perforation can inoculate viable bacteria directly into the sterile intra-articular joint cavity.
• Gross Synovial Fluid Inspection: Clear, straw-colored, and viscous fluid characterizes uncomplicated aseptic mechanical bursitis; bloody or serosanguinous fluid indicates acute traumatic hemobursa; cloudy, turbid, or frankly purulent fluid indicates septic bursitis or intense crystalline inflammation.
• Synovial Fluid Leukocyte Thresholds: In aseptic mechanical bursitis, the WBC count is typically <2,000/μL (rarely up to 5,000/μL) with <50% polymorphonuclear leukocytes (PMNs). In crystalline bursitis, WBC counts range from 5,000 to >50,000/μL with >70% PMNs. In septic bursitis, the WBC count typically exceeds 10,000/μL to 50,000/μL (with mean values between 30,000 and 80,000/μL) and >50% to 80% PMNs (frequently >90%). Diagnostic leukocyte thresholds in bursal fluid are lower than the traditional >50,000/μL cutoff for native joint septic arthritis due to smaller anatomical bursal volumes and cellular dilution kinetics.
• Microbiological Studies: Immediate Gram stain demonstrates Gram-positive cocci in clusters (S. aureus) or pairs/chains (streptococci) in approximately 40% to 60% of culture-confirmed infections; a negative Gram stain NEVER excludes septic bursitis. Aerobic and anaerobic cultures represent the definitive diagnostic benchmark for bacterial identification and antimicrobial susceptibility testing. Acid-fast bacilli (AFB) and fungal stains/cultures should be ordered in refractory, indolent, or immunocompromised presentations.
• Compensated Polarized Light Microscopy: Crucial to evaluate for needle-shaped, strongly negatively birefringent monosodium urate crystals (confirming gout) or rhomboid, weakly positively birefringent calcium pyrophosphate crystals (confirming pseudogout). The presence of crystals does not completely exclude concurrent bacterial infection, as coexistent crystalline and septic bursitis is well-documented.

Diagnostic Ultrasound & Advanced Magnetic Resonance Imaging (MRI)

Point-of-care musculoskeletal ultrasonography (POCUS) and magnetic resonance imaging (MRI) serve targeted diagnostic roles in challenging, complicated, or atypical clinical presentations:

• Musculoskeletal Ultrasound (POCUS): Highly accessible, cost-effective bedside modality utilizing a high-frequency (10–15 MHz) linear transducer. Demonstrates an anechoic or hypoechoic fluid collection distending the subcutaneous prepatellar space, bursal wall thickening (>2–3 mm) with internal hyperechoic septations or floating debris, and marked hypervascularity within the thickened bursal wall on Color and Power Doppler interrogation. Ultrasound confirms intact extensor mechanism continuity and verifies the absence of fluid distension in the suprapatellar recess, while providing real-time guidance for difficult needle aspirations.
• Magnetic Resonance Imaging (MRI): Reserved for diagnostic dilemmas, suspected deep extensor mechanism violation, immunocompromised patients with atypical indolent courses, or when assessing for suspected patellar osteomyelitis. T1-weighted sequences demonstrate well-demarcated low-to-intermediate signal fluid distension; replacement of normal high T1 patellar marrow signal by hypointense edema indicates contiguous osteomyelitis. T2-weighted and STIR sequences reveal bright hyperintensity within the fluid collection and surrounding soft-tissue edema. Post-gadolinium T1 sequences demonstrate thick, diffuse peripheral rim enhancement, mapping the absence or presence of deep capsular extension into the knee joint.

7. Classification

A validated etiological and clinical classification system directly governs therapeutic decision-making, differentiating self-limiting inflammatory presentations from life- and limb-threatening infectious emergencies:

8. Treatment

Medical / Nonoperative Management

Nonoperative management is the foundation of initial therapy and successfully resolves the vast majority of acute aseptic and uncomplicated septic prepatellar bursitis cases:

• Conservative Care — RICE Protocol: Rest, cryotherapy (crushed ice or cold pack applied for 20 minutes every 4 to 6 hours over a dry towel barrier), compression bandaging, and limb elevation above heart level during sedentary periods.
• Ergonomic Mechanical Offloading: Complete cessation of direct unpadded kneeling. When occupational activities mandate kneeling, workers must transition to commercial high-density gel-cushioned or articulated hard-shell knee protectors.
• Oral Anti-Inflammatory Pharmacotherapy: A 10-to-14-day course of oral nonsteroidal anti-inflammatory drugs (NSAIDs, e.g., naproxen 500 mg orally twice daily or ibuprofen 600 to 800 mg orally three times daily with food) or selective COX-2 inhibitors (celecoxib 200 mg daily), provided gastrointestinal and renal profiles permit.
• Therapeutic Decompression & Compressive Padding: For tense, painful effusions that restrict comfortable knee motion, complete needle aspiration under strict aseptic conditions affords immediate pain relief. Evacuation must be followed immediately by the placement of a localized foam compression pad taped firmly over the anterior patella and secured with an elastic tubular or cohesive compression bandage for 5 to 7 days to facilitate apposition of the bursal walls and prevent fluid recurrence.
• High Risk of Intrabursal Corticosteroid Injections: Although intrabursal injection of a long-acting corticosteroid (e.g., 20 to 40 mg triamcinolone acetonide) suppresses synoviocyte inflammation, multiple clinical trials and systematic reviews demonstrate a substantial 5% to 15% incidence of major complications, including localized subcutaneous adipose necrosis, dermal thinning, irreversible hypopigmentation, chronic draining cutaneous sinus tracts, and iatrogenic bacterial infection. Consequently, intrabursal corticosteroids must NEVER be utilized in the presence of unexplained erythema, suspected infection, or acute crystalline disease, and should be strictly restricted to chronic, recalcitrant aseptic cases that have failed multiple aspirations and compression regimens.
• Septic Bursitis Clinical Triage: Stratify patients into outpatient oral antibiotic therapy versus inpatient parenteral therapy based on hemodynamic stability, presence of systemic toxicity, extent of spreading cellulitis, host immune status, and reliability.
• Outpatient Oral Antimicrobial Regimens: First-line oral coverage targeting methicillin-sensitive S. aureus (MSSA) and streptococci: Cephalexin 500 mg orally four times daily, or Dicloxacillin 500 mg orally four times daily for 10 to 14 days. If community-acquired MRSA (CA-MRSA) is suspected based on local prevalence or risk factors: Trimethoprim-sulfamethoxazole (TMP-SMX) 1 to 2 double-strength tablets orally twice daily, Doxycycline 100 mg orally twice daily, or Clindamycin 300 to 450 mg orally three times daily (if local staphylococcal clindamycin resistance is <10–15%).
• Inpatient Intravenous Antimicrobial Regimens: For moderate-to-severe presentations (fever >38.5°C, systemic toxicity, rapid cellulitic extension, failed oral therapy, or immunocompromised hosts): Empirical IV therapy for MSSA: Cefazolin 1 to 2 g IV every 8 hours. Empirical IV therapy for suspected MRSA or sepsis: Vancomycin 15 to 20 mg/kg IV every 8 to 12 hours (adjusting for renal clearance; target trough level 15–20 μg/mL) OR Daptomycin 6 to 8 mg/kg IV once daily. Once afebrile for 24 to 48 hours, cellulitis is regressing, and bursal fluid clears, therapy is de-escalated to targeted oral agents to complete a total treatment duration of 10 to 14 days.
• Closed Needle Evacuation vs. Percutaneous Catheter Drainage: Serial daily or alternate-day percutaneous needle aspirations should be performed until fluid no longer re-accumulates and synovial cultures are sterile. For large, tense, purulent collections, bedside insertion of a 16-gauge angiocatheter or small-bore silastic drain into the dependent aspect of the bursa connected to a closed negative-pressure vacuum system provides continuous nonoperative drainage.

Operative Management (Bursectomy)

When conservative measures fail, surgical bursectomy provides definitive eradication of diseased bursal tissue. The fundamental goals of surgery are complete excision of the infected or chronically thickened fibrotic pseudocapsule, decompression of purulence, debridement of devitalized tissue, rigorous preservation of the extensor mechanism, and anatomical dead-space obliteration to prevent hematoma and recurrent seroma.

Open Bursectomy

Open bursectomy remains the time-tested surgical benchmark for complex, chronic, or severe phlegmonous prepatellar bursitis:

• Incision Architecture: A vertical straight midline longitudinal incision over the center of the patella must be strictly avoided. A longitudinal midline scar lies directly on the high-pressure contact zone during kneeling, predisposing to chronic disabling scar pain, hypertrophic scar formation, and recurrent skin breakdown. The optimal incision is either a transverse/horizontal incision placed directly within Langer’s relaxed skin tension lines over the middle of the patella, or a lateral parapatellar curvilinear incision situated 1 to 2 cm lateral to the patellar border.
• Surgical Dissection & Flap Elevation: Elevate full-thickness subcutaneous skin flaps. It is essential to preserve at least 4 to 5 mm of subcutaneous adipose tissue attached to the overlying skin flap to protect the subdermal microvascular plexus and avoid full-thickness ischemic skin necrosis. Identify the superficial adventitial wall of the bursal sac.
• Bursal Excision & Periosteal Preservation: Develop the extra-articular plane circumferentially around the thickened pseudocapsule using sharp dissection and bipolar electrocautery. Mobilize the bursal sac from superior to inferior. The deep bursal wall is intimately adherent to the prepatellar aponeurosis and anterior patellar periosteum. Dissect sharply directly across the deep bursal wall without denuding the anterior cortical bone of the patella down to bare bleeding osseous cortex. Preserving the thin, vascularized prepatellar aponeurotic and periosteal sleeve protects the prepatellar arterial rete, avoids patellar ischemia, and provides a viable bed that promotes rapid adherence of the overlying subcutaneous flap.
• Hemostasis, Drainage & Layered Closure: Achieve meticulous hemostasis using bipolar cautery. Copiously irrigate the surgical dead space with sterile normal saline. Insert a 7 mm or 10 Fr closed-suction silicone drain (e.g., Jackson-Pratt or Blake) through a separate superolateral stab incision, positioning the perforated tubing across the entire debrided prepatellar bed. Close the deep subcutaneous tissue with interrupted 3-0 absorbable sutures and the skin with 4-0 non-absorbable monofilament sutures in an interrupted horizontal mattress configuration. Apply a bulky compressive bolster dressing and immobilize the knee in extension with a removable knee brace for 48 to 72 hours.

Endoscopic / Arthroscopic Bursectomy

Endoscopic bursectomy is a validated, minimally invasive surgical alternative that affords outstanding visualization, substantially smaller cutaneous scars, lower wound complication rates, and accelerated functional recovery:

• Patient Positioning & Portal Placement: Position the patient supine with a pneumatic thigh tourniquet applied. Establish two extra-articular subcutaneous portals located 1 to 2 cm outside the bursal perimeter: a superolateral portal (primary viewing portal) and an inferolateral portal (primary instrumentation portal). Alternatively, a high-lateral and a low-medial portal can be utilized for broad triangulation.
• Instrumentation & Resection Technique: Introduce a standard 4.0 mm 30-degree arthroscope into the prepatellar subcutaneous space. Infuse sterile saline under gravity or low mechanical pump pressure (≤30–40 mmHg) to distend the bursal cavity without forcing fluid into the surrounding fascial planes. Introduce a 3.5 mm or 4.2 mm aggressive motorized synovial shaver or radiofrequency ablation wand through the working portal.
• Cutaneous Transillumination Safety Rule: Dim the ambient operating room lights and observe cutaneous transillumination through the anterior skin envelope. Direct the shaver suction opening downward toward the rigid patellar floor and away from the dermal surface. This prevents mechanical or thermal laceration of the subdermal capillary plexus, ensuring skin viability. Systematically resect the hyperplastic synovial roof, internal septations, and fibrotic floor down to healthy aponeurosis.
• Closure & Drain: Thoroughly aspirate all irrigation fluid, insert a small closed-suction drain through the inferolateral portal, close portals with simple nylon sutures, and apply a compressive bolster wrap.

One-Stage vs. Two-Stage Bursectomy for Severe Septic Bursitis

Surgical management of severe septic bursitis historically relied upon a two-stage approach (radical excision with delayed secondary closure or packing). However, contemporary Level I evidence from a randomized controlled trial by Uçkay et al. establishes that a one-stage bursectomy (complete bursal excision with primary wound closure over a closed-suction drain, combined with targeted systemic antibiotic therapy) achieves identical clinical cure rates (100%), reduces hospital length of stay by nearly 50% (median 4.0 days vs. 7.0 days), and substantially decreases postoperative wound dressing morbidity. A two-stage procedure is reserved strictly for neglected cases featuring extensive full-thickness cutaneous necrosis, florid subcutaneous abscess formation, or massive peribursal phlegmon where primary closure is mechanically precluded without excessive wound tension.

Indications & Contraindications

Strict clinical triggers and objective thresholds govern surgical decision-making:

• Septic Bursitis Refractory Threshold: Failure of acute septic bursitis to show objective clinical improvement (persistent fever, expanding erythema, lack of decrease in fluid leukocyte count) after 48 to 72 hours of targeted intravenous or oral antibiotic therapy and closed drainage.
• Tissue Necrosis & Phlegmon Trigger: Septic bursitis presenting with acute full-thickness cutaneous necrosis, spontaneous purulent fistulization, or extensive subcutaneous peribursal abscess formation mandates immediate operative debridement.
• Aseptic Chronicity Threshold: Chronic, recurrent, or disabling aseptic bursitis that has failed at least 3 to 6 months of comprehensive conservative management (including ≥2 complete therapeutic aspirations, compressive bandaging, and ergonomic offloading).
• Gouty Tophi Trigger: Large, calcified, ulcerative tophaceous gout of the prepatellar bursa refractory to medical urate-lowering therapy.
• Systemic Instability Contraindication: Active uncontrolled systemic bacteremia or profound hemodynamic instability mandates initial medical resuscitation and parenteral antimicrobial stabilization prior to elective or semi-elective bursal surgery.
• Overlying Cellulitis Contraindication: Active, spreading cutaneous cellulitis overlying the intended surgical field in patients undergoing elective bursectomy for chronic aseptic bursitis mandates postponing surgery until active dermatitis is completely eradicated.
• Concomitant Joint Sepsis Contraindication: Concomitant intra-articular septic arthritis of the knee joint requires formal urgent knee joint arthroscopy or arthrotomy and joint lavage, rather than isolated extra-articular bursectomy.

9. Outcome

Prognostic outcomes in prepatellar bursitis correlate directly with underlying etiology, promptness of therapeutic decompression, and adherence to ergonomic offloading:

• Nonoperative Resolution Rates: Conservative therapy (cryotherapy, compressive bandaging, NSAIDs, and activity modification) successfully resolves 85% to 90% of acute aseptic cases within 2 to 4 weeks. In acute uncomplicated septic bursitis, outpatient or inpatient antibiotic therapy combined with serial needle aspirations achieves definitive infection clearance in 70% to 80% of cases without requiring operative intervention.
• Recurrence Rates Post-Aspiration: In chronic aseptic bursitis, isolated needle aspiration without continuous compressive bandaging or kneeling cessation carries a recurrence rate of 30% to 50% within 6 months.
• Recurrence & Complication Rates Post-Bursectomy: Recurrence rates following meticulous open bursal excision range from 2% to 5%, but open excision carries a 10% to 20% incidence of wound-related complications, including wound edge necrosis, hematoma, and prolonged scar hypersensitivity. Endoscopic bursectomy demonstrates comparable low recurrence rates of 3% to 7%, but with significantly lower overall wound complication rates (2% to 4%) and superior patient satisfaction regarding cosmetic appearance.
• Return to Work & Functional Recovery: Patients undergoing endoscopic bursectomy achieve full wound healing and return to unrestricted occupational kneeling in an average of 3 to 4 weeks, compared to 6 to 8 weeks following open bursectomy.
• Validated Patient-Reported Outcome Measures (PROMs): Surgical bursectomy reliably restores knee function. Postoperative cohorts demonstrate statistically and clinically significant improvements in Lysholm Knee Scoring Scale metrics, increasing from a preoperative baseline of 62–68 points to postoperative scores exceeding 88 to 92 points. Tegner Activity Scale scores return to pre-injury baseline in >90% of athletic and occupational patients. Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales for pain, activities of daily living, and sports/recreation demonstrate sustained recovery at 1- and 2-year longitudinal follow-up.

10. Complications

Complications associated with prepatellar bursitis and its surgical management span intraoperative technical misadventures, early wound healing failures, and chronic late functional limitations:

11. Pearls and Pitfalls

• The Extra-Articular Needle Trajectory Pearl: When performing diagnostic or therapeutic aspiration of a distended prepatellar bursa, always insert the needle through intact, normal skin lateral to the patella and advance parallel to the anterior cortical plane. Never enter through an area of central skin erythema or necrosis, and never angle the needle toward the joint space or patellar tendon. This eliminates the risk of creating an iatrogenic conduit into the sterile knee joint cavity.
• The 90-Degree Passive Flexion Benchmark: If a patient presenting with an acutely swollen, hot, erythematous anterior knee can comfortably tolerate passive knee flexion up to 90 degrees or beyond, the pathology is virtually guaranteed to be extra-articular (prepatellar bursitis). This simple physical finding immediately prevents the catastrophic error of taking a patient to the operating room for an emergency intra-articular knee arthrotomy.
• Incision Architecture Pearl: Never make a straight longitudinal midline incision over the patella. Always utilize a transverse incision following Langer’s relaxed skin tension lines over the middle of the patella, or a lateral parapatellar approach. A transverse incision distributes kneeling tension across the scar rather than pulling it apart, virtually eliminating the painful anterior scar tethering that notoriously prevents workers from returning to kneeling trades.
• The Endoscopic Transillumination Safety Rule: During endoscopic bursectomy, continuously dim the ambient operating room lighting to observe light transmission through the anterior skin flap. Direct the shaver suction aperture downward toward the patellar floor and away from the dermis. This ensures that the motorized blade never violates the critical subdermal capillary plexus, preventing full-thickness skin necrosis.
• Mandatory Dead-Space Obliteration: Following bursal excision, a large potential dead space remains over the anterior patella. Always place a closed-suction silicone drain and maintain a firm, padded compressive bolster dressing for 5 to 7 days postoperatively. Premature drain removal before output drops below 20 to 30 mL/24h invariably leads to a tense postoperative seroma that mimics recurrent bursitis.
• The Periosteal Preservation Pearl: When excising the deep bursal wall, never strip the anterior patella down to bare cortical bone. Leaving a microscopically thin, viable layer of vascularized prepatellar aponeurosis and periosteum preserves the patellar arterial rete, prevents localized bone ischemia, and provides an adherent, vascularized bed for the overlying skin flap.
• The Corticosteroid Inadvertence Pitfall: Never inject corticosteroids into an acutely swollen bursa before fluid analysis and microbiological cultures have conclusively excluded bacterial infection. Injecting steroids into an unverified effusion can transform a localized staphylococcal inoculation into fulminant necrotizing cellulitis, persistent cutaneous sinus tracts, and patellar osteomyelitis.

12. Controversy

Several clinical debates continue to influence decision-making in the management of prepatellar bursitis:

Intrabursal Corticosteroid Injections in Aseptic Bursitis: Efficacy vs. Complication Risk

The role of intrabursal corticosteroid injection in acute and chronic aseptic bursitis remains highly contentious. While corticosteroid infiltration achieves rapid symptomatic relief and accelerated effusion resolution, extensive clinical registries and systematic reviews document a 5% to 15% rate of major adverse events, including full-thickness dermal atrophy, skin depigmentation, persistent cutaneous fistulae, and iatrogenic secondary infection. Proponents argue that in chronic non-septic bursitis refractory to repeated aspirations, low-dose intermediate-solubility steroids combined with rigorous compressive bandaging provide definitive nonoperative cure. Opponents maintain that the risk-to-benefit profile is unfavorable in an anatomically superficial, subcutaneous site like the anterior patella, and advocate that refractory cases should proceed to minimally invasive endoscopic bursectomy rather than steroid injection.

Endoscopic vs. Open Bursectomy

Discourse persists regarding whether endoscopic bursectomy should fully supplant traditional open excision. Endoscopic techniques offer smaller cosmetic incisions, significantly lower wound dehiscence and infection rates (2% to 4% vs. 10% to 20%), and accelerated return to work (3 to 4 weeks vs. 6 to 8 weeks). However, critics highlight that endoscopic bursectomy requires specialized arthroscopic equipment, incurs higher procedural costs, and demands a defined learning curve to avoid inadvertent skin flap laceration or incomplete bursal resection. In chronic cases with dense fibrotic calcifications or large tophaceous gouty deposits, open excision often provides more reliable, complete pseudocapsule removal under direct visual control.

One-Stage vs. Two-Stage Bursectomy for Septic Bursitis

Surgical management of septic bursitis historically mandated a two-stage approach comprising initial open incision and debridement followed by secondary delayed closure or prolonged open packing, based on fears that immediate primary closure would entrap residual bacteria and cause recurrent abscess formation. However, high-quality Level I prospective randomized controlled trial data from Uçkay et al. demonstrated that one-stage bursectomy with primary wound closure over a closed-suction drain, combined with targeted systemic antibiotic therapy, achieved a 100% cure rate identical to the two-stage technique. Furthermore, one-stage bursectomy significantly reduced median hospital length of stay (4.0 days vs. 7.0 days) and eliminated the substantial pain and nursing costs associated with repeated open dressing changes. Clinical consensus now strongly favors one-stage bursectomy over a drain for acute septic bursitis, reserving two-stage surgery strictly for cases with severe cutaneous necrosis or gross wound contamination.

Conservative Serial Aspiration vs. Immediate Bursectomy for Septic Bursitis

Debate continues regarding the optimal timing of surgical intervention in uncomplicated acute septic prepatellar bursitis. Some surgical centers advocate immediate primary bursectomy at initial diagnosis, arguing that early surgical excision shortens total antibiotic duration and definitively eliminates the infected focus. Conversely, mainstream infectious disease and orthopaedic consensus supports an initial 48-to-72-hour trial of conservative therapy comprising targeted intravenous or oral antibiotics coupled with serial closed needle aspirations or catheter drainage. Conservative therapy successfully resolves 70% to 80% of uncomplicated septic bursitis cases, thereby sparing the patient the costs, surgical risks, and potential wound morbidity of an operative bursectomy.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Brown OS, Smith TO, Parsons T et al. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022. doi:10.1007/s00402-021-03853-9 [Level I: Systematic Review / Meta-Analysis]
• Baumbach SF, Lobo CM, Badyine I et al. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014. doi:10.1007/s00402-013-1882-7 [Level I: Systematic Review / Meta-Analysis]
• Uçkay I, von Dach E, Perez C et al. One- vs 2-Stage Bursectomy for Septic Olecranon and Prepatellar Bursitis: A Prospective Randomized Trial. Mayo Clin Proc. 2017. doi:10.1016/j.mayocp.2017.03.011 [Level I: Randomized Controlled Trial]
• CHARLES G. PETERFY, Ali Guermazi, Syafawati Zaim et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis and Cartilage. 2003. doi:10.1016/j.joca.2003.11.003 [Level IV (Prognostic / Case Series): Seminal Conceptual / Observational Study]
• M. Backhaus, G-R Burmester, T Gerber et al. Guidelines for musculoskeletal ultrasound in rheumatology. Annals of the Rheumatic Diseases. 2001. doi:10.1136/ard.60.7.641 [Level IV (Prognostic / Case Series): Seminal Conceptual / Observational Study]

15. Master Class Pro-Tip

When undertaking an open bursectomy for chronic refractory or recurrent prepatellar bursitis, the paramount surgical pearl is to resist the temptation of denuding the anterior patellar cortex down to bare cortical bone. The deep wall of the prepatellar bursa is intimately attached to the anterior prepatellar aponeurosis and underlying periosteum; dissecting directly into this fibrous expansion devascularizes the anterior cortical bone and destroys the patellar arterial rete, leaving an avascular bed that cannot support the overlying thinned skin flap. Instead, sharply excise the thickened fibrous bursal pseudocapsule while leaving a microscopically thin, viable layer of vascularized prepatellar aponeurotic tissue intact over the bone. Furthermore, always utilize a transverse incision following Langer’s relaxed skin tension lines across the mid-patella rather than a traditional midline longitudinal incision. A transverse scar lies within the flexion folds, distributing kneeling pressure evenly and preventing the chronic, disabling anterior scar tethering and painful neuroma formation that notoriously preclude trade workers from returning to occupational kneeling.

Master Class Surgical Pearl: Prepatellar Bursal Excision & Extensor Mechanism Preservation